New Data: Little Weight Rebound After Stopping Ozempic, Wegovy

New research challenges fears of quick weight regain after stopping GLP-1 drugs like Ozempic and Wegovy. Real-world data reveals many patients sustain their losses. Experts say durability is possible without lifelong treatment.

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

Real-World Insights Challenge Clinical Trial Findings

Many patients using highly effective GLP-1 drugs may not regain lost weight quickly when they stop treatment. This comes from an analysis of real-world data addressing a key concern about these therapies.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

The data contradicts findings from Novo Nordisk's clinical trials, which warned that many patients regain weight soon after interrupting treatment.

Expert Views on Long-Term Use

Obesity specialists have questioned whether people need these medicines for years to keep benefits.

"The implication of our real-world evidence is not that rebound risk is negligible, but rather that durability is achievable in routine care," said Nference chief scientific officer Venky Soundararajan.

Source Information

Originally published by South China Morning Post.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies

Two generic versions of Ozempic have arrived in Canadian pharmacies, offering diabetes and weight loss patients significant cost savings compared to the brand-name medication.

7 min read

Health & Wellness

Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means

Eli Lilly's Retatrutide has shown remarkable weight loss potential in Phase 3 trials. We break down the TRIUMPH-1 results, safety data, and what patients can expect.

9 min read

Health & Wellness

Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine

New regulations warn that GLP-1 medication users could face significant fines if side effects impair driving. Here is the complete guide to staying safe and compliant.

8 min read

Same topic: Ozempic

All Ozempic articles →

GLP-1 Medications

How to Keep Weight Off After Ozempic: Proven Strategies

Stopping Ozempic often leads to weight regain—up to 7% in trials or two-thirds within a year. While continuing semaglutide helps sustain losses, lifestyle changes and maintenance dosing offer alternatives. Work with your healthcare team for a personalized plan to keep the weight off long-term.

6 min read

GLP-1 Medications

Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story

Ozempic isn't just transforming waistlines—it's igniting a surge in hot sauce sales like Tapatío's. As millions embrace GLP-1 drugs, cravings for bold flavors skyrocket, propelling L.A.'s iconic brand into national expansion under new owners Highlander Partners. This is the untold story of family legacy meeting metabolic health trends.

5 min read

GLP-1 Medications

Taking GLP-1s? Doctors Stress Movement and Mental Health Too

Jelon Smart from Savannah dropped 110 pounds on Ozempic—but credits her intensive workout regimen too. Facing severe ankle swelling from Achilles tendinitis at 285 pounds, she transformed her life. Doctors remind GLP-1 users: movement and mental health are essential alongside medication.

5 min read

More in GLP-1 Medications

Weight Management

Retatrutide: A New Era in Weight Loss Drugs vs. Ozempic

Eli Lilly's experimental drug retatrutide has demonstrated unprecedented weight loss results in a pivotal trial. This article delves into its mechanisms, efficacy, safety, and how it stacks up against current leading weight loss medications like Ozempic and Wegovy.

6 min read

Health & Wellness

FDA Warning: How to Spot Fake Tirzepatide and Stay Safe on Weight Loss

The FDA has issued a critical warning regarding counterfeit tirzepatide products. Discover the risks of fake GLP-1 medications and how to verify legitimate sources for your weight loss journey.

6 min read

Health & Wellness

Generic Semaglutide Launches in Canada: What Patients Need to Know

The Canadian market sees the arrival of a generic semaglutide injection, a significant development for individuals managing type 2 diabetes and seeking weight loss solutions. This launch by Dr. Reddy's Laboratories marks a new era of accessibility for this popular GLP-1 therapy.

7 min read